The Pap smear is perhaps the most well-known method of cervical cancer screening. First introduced in 1928 and widely adopted ...

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat ...

Highlighting the dire consequences if no action is taken, he said, "If we do not act, Pakistan will face over 11 million HCV cases by 2035, leading to 500,000 plus liver cirrhosis cases, over 100,000 ...

Denver would eliminate its limit on the number of needle exchange programs that can operate in the city and remove ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest ...

ICMR draft NEDL aims to enhance diagnostic services in India, seeking public feedback for comprehensive healthcare ...

Tackle cancer risk with evidence-based resolutions inspired by the Latin American and Caribbean Code Against Cancer.

It's JPM 2025 and here at Fierce Biotech we’re bringing you all the latest updates live from the life sciences event of the ...

Ongoing commercial launch of AUCATZYL® on track, with 24 treatment centers fully authorized as of January 10th- National Comprehensive Cancer ...

Britain's first drug consumption room opens today in Glasgow in what Scotland's First Minister's branded a "significant step ...

NDAQ:HUMA) Humacyte Provides Update on Commercial Launch and Pricing of Symvess(TM) (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma ...